We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Latest Real-Time PCR System Incorporates Innovative Glass Fiber Optics

By LabMedica International staff writers
Posted on 21 Nov 2012
The newest 96-well format Real Time PCR instrument is now available for genomics and genetics researchers.

PCR (polymerase chain reaction) is a key technology in life science research and molecular diagnostics in which a segment of nucleic acid (DNA or RNA) is copied or “amplified” so that it can be more readily analyzed. More...
Real-time PCR is a modification of standard PCR and provides greater accuracy in applications such as the quantification of gene expression, proteins, viruses, and bacteria in human, food, and soil samples, and for analysis of mutations (SNP), detection of gene modified organisms (GMO), and forensic testing. The process involves cycles of alternative heating and cooling of a small sample containing the nucleic acid. Throughout this process, copies of targeted DNA molecules are produced and the amount of the amplified DNA is measured during the PCR process in real-time. This ensures very accurate and precise quantification of the nucleic acid.

The new instrument – the Roche (Basel, Switzerland) LightCycler 96 system – incorporates innovative glass fiber optics capable of equal and simultaneous data capture from all 96 wells, while avoiding the signal variations commonly seen in systems that use optical scanning. The instrument is described as being highly accurate, reproducible, and capable of fast data generation. In addition, the LightCycler 96 is calibration- free, as it does not require a passive reference dye.

“The LightCycler 96 System reflects more than a decade of Roche expertise and continuous innovation in PCR technology and brings the high quality and reliability of our PCR systems within the reach of every researcher,” said Gerd Haberhausen, head of qPCR and sample preparation systems at Roche. “The instrument’s new silver block ensures outstanding temperature homogeneity and therefore enables a maximum of data consistency and accuracy. In addition, the new Light Cycler 96 puts the user right at the center by providing highly intuitive, user-friendly software and interfaces.”

Related Links:
Roche



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.